Current Research Information SysTem In Norway
 
 

 English version


 
Hovedside
Forskningsresultater/NVI
Forskere
Prosjekter
Forskningsenheter
Logg inn
Om Cristin
 
 
   
Eksporter til


Viser treff 1-50 av 121 << Forrige 1 2 3    Neste >>

2012
1 Wisløff, Finn Georg B.
Kvalitet i medisinsk forskning : hva er det?. I: Medisinsk kunnskap - Hvor kommer den fra, og hva brukes den til?. Gyldendal Akademisk 2012 ISBN 978-82-05-39912-9. s. 64-76
OUS UiO Untitled
 
2 Wisløff, Finn Georg B; Fossum, Sigbjørn.
Forskning viser at ... Vurdering og formidling av medisinske forskningsresultater. Gyldendal Akademisk 2012 (ISBN 978-82-05-42551-4) 359 s.
OUS UiO Untitled
 
2011
3 Kvam, Ann Kristin; Fayers, Peter; Wisløff, Finn Georg B.
Responsiveness and minimal important score differences in quality-of-life questionnaires: a comparison of the EORTC QLQ-C30 cancer-specific questionnaire to the generic utility questionnaires EQ-5D and 15D in patients with multiple myeloma. European Journal of Haematology 2011 ;Volum 87.(4) s. 330-337
AHUS NTNU OUS UiO Untitled
 
4 Kvam, Ann Kristin.
Health-related quality of life in patients with multiple myeloma : what makes a difference to the patient?. Unipub forlag 2011 (ISBN 978-82-8264-137-1) Series of dissertations submitted to the Faculty of Medicine, University of Oslo(1141)
UiO Untitled
 
2010
5 Waage, Anders; Gimsing, P; Fayers, Peter; Abildgaard, N; Ahlberg, L; Bjorkstrand, B; Carlson, K; Dahl, Inger Marie; Forsberg, K; Gulbrandsen, Nina; Haukås, Einar; Hjertner, Øyvind; Hjorth, M; Karlsson, T; Knudsen, LM; Nielsen, JL; Linder, O; Mellqvist, UH; Nesthus, Ingerid; Rolke, J; Strandberg, M; Sørbø, Jon Hjalmar; Wisløff, Finn; Juliusson, G; Turesson, I.
Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma. Blood 2010 ;Volum 116.(9) s. 1405-1412
HAUKELAND HNT NTNU OUS STO SUS UiO UNN Untitled
 
6 Finset, Arnstein; Wisløff, Finn Georg B; Jacobsen, Jørn E.; Fyrand, Live.
Utfordring og mulighet: en helsetjeneste i endring. Unipub forlag 2010 (ISBN 978-82-303-1552-1) 219 s.
SIV UiO Untitled
 
7 Gimsing, Peter; Carlson, Kristina; Turesson, Ingemar; Fayers, Peter; Waage, Anders; Vangsted, Annette; Mylin, Anne; Gluud, Christian; Juliusson, Gunnar; Gregersen, Henrik; Hjorth-Hansen, Henrik; Nesthus, Ingerid; Dahl, Inger Marie; Westin, Jan; Lanng Nielsen, Johan; Knudsen, Lene M; Ahlberg, Lucia; Hjorth, Martin; Abildgaard, Niels; Andersen, Niels F; Linder, Olle; Wisløff, Finn Georg B.
Effect of pamidronate 30mg versus 90mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial. The Lancet Oncology 2010 ;Volum 11.(10) s. 973-982
HAUKELAND NTNU OUS STO UiO UNN Untitled
 
8 Iversen, Per Ole; Wisløff, Finn Georg B; Gulbrandsen, Nina.
Reduced nutritional status among multiple myeloma patients during treatment with high-dose chemotherapy and autologous stem cell support. Clinical Nutrition 2010 ;Volum 29.(4) s. 488-491
OUS UiO Untitled
 
9 Kvam, Ann K.; Fayers, Peter; Wisløff, Finn.
What changes in health-related quality of life matter to multiple myeloma patients? A prospective study. European Journal of Haematology 2010 ;Volum 84.(4) s. 345-353
NTNU OUS UiO Untitled
 
10 Kvam, Ann Kristin; Wisløff, Finn Georg B; Fayers, Peter.
Minimal important differences and response shift in health-related quality of life; a longitudinal study in patients with multiple myeloma. Health and Quality of Life Outcomes 2010 ;Volum 8.(79) s. -
NTNU OUS UiO Untitled
 
11 Smeland, Erlend B; Vartdal, Frode; Wisløff, Finn Georg B.
Ledelse og akademisk kompetanse. Tidsskrift for Den norske legeforening 2010 ;Volum 130.(6) s. 591-
OUS UiO Untitled
 
12 Smeland, Erlend B; Vartdal, Frode; Wisløff, Finn Georg B.
Tett samarbeid, men ikke overstyring. Tidsskrift for Den norske legeforening 2010 ;Volum 130.(6) s. 590-591
OUS UiO Untitled
 
2009
13 Dahl, Inger Marie S.; Wisløff, Finn; Børset, Magne; Mella, Olav.
Myelomatose. I: Medikamentell kreftbehandling. Cytostatikaboken. Oslo: Farmakologisk institutt, DMF, UiO 2009 ISBN 978-829923312-5. s. 346-356
NTNU Untitled
 
14 Kvam, AK; Fayers, Peter; Hjermstad, Marianne Jensen; Gulbrandsen, N; Wisloff, F; Wisløff, Finn Georg B.
Health-related quality of life assessment in randomised controlled trials in multiple myeloma: a critical review of methodology and impact on treatment recommendations. European Journal of Haematology 2009 ;Volum 83.(4) s. 279-289
NTNU OUS UiO Untitled
 
2008
15 Aasbrenn, Martin; Langmark, Frøydis; Wisløff, Finn Georg B.
Er registreringen av myelomatose i Kreftregisteret god nok?. Tidsskrift for Den norske legeforening 2008 ;Volum 128.(23) s. 2712-2714
UiO Untitled
 
16 Aasbrenn, Martin; Langmark, Frøydis; Wisløff, Finn Georg B.
Er registreringen av myelomatose i Kreftregisteret god nok?. Tidsskrift for Den norske legeforening 2008 ;Volum 128.(23)
VID KREFTREG UiO Untitled
 
17 Benestad, Haakon Breien; Wisløff, Finn Georg B.
Forskningsetikk og Universitetet i Oslo. Tidsskrift for Den norske legeforening 2008 ;Volum 128.(15) s. 1683-1684
UiO Untitled
 
18 Iversen, Per Ole; Ukrainchenko, Ekaterina; Afanasyev, Boris; Hulbekkmo, Kristin; Choukah, Amal; Gulbrandsen, Nina; Wisløff, Finn Georg B; Tangen, Jon-Magnus.
Impaired nutritional status during intensive chemotherapy in Russian and Norwegian cohorts with acute myeloid leukemia. Leukemia and Lymphoma 2008 ;Volum 49.(10) s. 1916-1924
OUS UiO Untitled
 
2007
19 Galli, M; Borrelli, G; Jacobsen, Eva Marie; Marfisi, RM; Marchioli, R; Wisløff, Finn Georg B; Marziali, S; Barbui, T.
Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study. Blood 2007 ;Volum 110. s. 1178-1183
UiO Untitled
 
20 Liestøl, Sigurd; Sandset, Per Morten; Jacobsen, Eva Marie; Mowinckel, Marie-Christine; Wisløff, Finn Georg B.
Decreased anticoagulant response to tissue factor pathway inhibitor type 1 in plasmas from patients with lupus anticoagulants. British Journal of Haematology 2007 ;Volum 136. s. 131-137
UiO Untitled
 
21 Cocks, K; Cohen, D; Wisløff, Finn Georg B; Sezerc, O; Lee, S; Hippe, E; Gimsing, P; Turesson, I; Hajek, R; Smith, A; Graham, L; Phillips, A; Stead, M; Velikova, G; Brown, J.
An internadional field study of the reliability and validity of a disease-specfic questionnanire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma. European Journal of Cancer 2007 ;Volum 43. s. 1670-1678
OUS UiO Untitled
 
22 Liestøl, Sigurd; Sandset, Per Morten; Mowinckel, M.C.; Wisløff, Finn Georg B.
Activated protein C resistance determined with a thrombin generation-based test is associated with thrombotic events in patients with lupus anticoagulants. Journal of Thrombosis and Haemostasis 2007 ;Volum 5.(11) s. 2204-2211
OUS UiO Untitled
 
23 Sandset, Per Morten; Wisløff, Finn Georg B.
Blodsykdommer. I: Norsk legemiddelhåndbok for helsepersonell 2007. Oslo: Foreningen for utgivelse av Norsk Legemiddelhåndbok 2007 ISBN 978-82-90732-09-2. s. 147-172
UiO Untitled
 
24 Sandset, Per Morten; Wisløff, Finn Georg B.
Legemidler og bruken av dem. I: Legemidler og bruken av dem. Gyldendal Akademisk 2007 ISBN 978-82-05-32365-0. s. 197-204
UiO Untitled
 
25 Sandset, Per Morten; Wisløff, Finn Georg B.
Legemidler ved blodsykdommer. I: Norsk legemiddelhåndbok for helsepersonell 2007. Oslo: Foreningen for utgivelse av Norsk Legemiddelhåndbok 2007 ISBN 978-82-90732-09-2. s. 815-848
UiO Untitled
 
26 Wisløff, Finn Georg B; Kvam, Ann Kristin; Hjorth, Martin; Lenhoff, Stig.
Serum calcium is an independent predictor of quality of life in multiple myeloma. European Journal of Haematology 2007 ;Volum 78. s. 29-34
UiO Untitled
 
2006
27 Lenhoff, Stig; Hjorth, Martin; Turesson, Ingemar; Westin, Jan; Gimsing, Peter; Wisløff, Finn Georg B; Ahlberg, L; Carlson, Kristina; Christiansen, Ilse; Dahl, Inger Marie; Forsberg, K; Gedde-Dahl, Tobias Jr.; Hammerstrøm, Jens; Johnsen, Hans; Knudsen, Lene; Linder, Olle; Mellqvist, Ulf-Henrik; Nesthus, Ingerid; Nielsen, Johan Langg.
Intensive therapy for multiple myeloma in patients younger than 60 years. Long-term results with focus on the effect of response degree on survival and relapse pattern after transplantation. Studies in Surface Science and Catalysis 2006 ;Volum 91. s. 1228-1233
UiO Untitled
 
28 Jacobsen, EM; Trettenes, EJ; Wisløff, Finn Georg B; Abildgaard, Ulrich.
Detection and quantification of lupus anticoagulants in plasma from heparin treated patients, using addition of polybrene. Thrombosis Journal 2006 ;Volum 4. s. 3-8
UiO Untitled
 
29 Sullivan, Daniel; Singhal, Seema; Schuster, Micael; Gimsing, Peter; Wisløff, Finn; Waage, Anders; Alsina, Melissa; Gerwien, Robert; Clarke, Anne; Møller, Karen; Ooi, Chean Eng.
A phase II study of PDX 101 in advanced multiple myeloma. 48th Annual Meeting; 2006-12-09
NTNU OUS STO Untitled
 
2005
30 Crowther, MA; Wisløff, Finn Georg B.
Evidence based treatment of the anti phospholipid syndrome II. Optimal anticoagulant therapy for thrombosis. Thrombosis Research 2005 ;Volum 115.
OUS UiO Untitled
 
31 Finazzi, G; Marchioli, R; Brancaccio, V; Schinco, P; Wisløff, Finn Georg B; Musial, J; Baudo, F; Berrettini, M; Testa, S; D'Angelo, A; Tognoni, G; Barbui, T.
A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). Journal of Thrombosis and Haemostasis 2005 ;Volum 3(5). s. 848-853
OUS UiO Untitled
 
32 Guren, Tormod Kyrre; Christoffersen, Thoralf; Thoresen, G. Hege; Wisløff, Finn Georg B; Tveit, Magne Kjell; Dajani, Olav.
Antitumormidler rettet mot tyrosinkinaser. Tidsskrift for Den norske legeforening 2005 (Årg. 125, nr 22) s. 3115-3119
OUS UiO Untitled
 
33 Hippe, E; Westin, J; Wisløff, Finn Georg B.
Nordic Myeloma Study Group, the first 15 years: scientific collaboration and improvement of patient care. European Journal of Haematology 2005 ;Volum 74(3). s. 185-193
OUS UiO Untitled
 
34 Liestøl, Sigurd; Wisløff, Finn Georg B.
Effect of subcutaneous administration of dalteparin on lupus anticoagulant assays. Thrombosis Research 2005 ;Volum 115(6). s. 509-517
OUS UiO Untitled
 
35 Smith, A; Wisløff, Finn Georg B; Samson, D.
Guidelines on the diagnosis and management of multiple myeloma 2005. British Journal of Haematology 2005 ;Volum 132. s. 410-451
UiO Untitled
 
36 Wisløff, Finn Georg B; Gulbrandsen, Nina; Hjorth, M; Lenhoff, S; Fayers, P..
Quality of life may be affected more by disease parameters and response to therapy than by haemoglobin changes. European Journal of Haematology 2005 ;Volum 75(4). s. 293-298
OUS UiO Untitled
 
2004
37 Waage, Anders; Gimsing, Peter; Juliusson, Gunnar; Turesson, Ingemar; Gulbrandsen, Nina; Eriksson, Tommy; Hjorth, Martin; Nielsen, Johan L.; Lenhoff, Stig; Westin, Jan; Wisløff, Finn.
Early response predicts thalidomide efficiency in patients with advanced multiple myeloma. British Journal of Haematology 2004 ;Volum 125. s. 149-155
NTNU Untitled
 
38 Gulbrandsen, Nina; Hjermstad, Marianne Jensen; Wisløff, Finn Georg B.
Interpretation of quality of life scores in multiple myeloma by comparison with a reference population and assessment of the clinical importance of score differences. European Journal of Haematology 2004 ;Volum 72. s. 172-180
UiO Untitled
 
39 Waage, Anders; Gimsing, Peter; Juliusson, Gunnar; Turesson, Ingemar; Gulbrandsen, Nina; Eriksson, T; Hjorth, Martin; Nielsen, Johan Langg; Lenhoff, Stig; Westin, Jan; Wisløff, Finn Georg B.
Early response predicts thalidomide efficiency in patients with advanced multiple myeloma. British Journal of Haematology 2004 ;Volum 125. s. 149-155
UiO Untitled
 
40 Wisløff, Finn Georg B; Crowther, M.
Evidence-based treatment of the antiphospholipid syndrome I. Pregnancy failure. Thrombosis Research 2004 ;Volum 114. s. 75-81
UiO Untitled
 
2003
41 Evensen, Stein A.; Brinch, Lorentz; Hammerstrøm, Jens; Wisløff, Finn; Waage, Anders.
Leukemi hos voksne. Kap. 22. Cytostatikaboken 2003
NTNU UiO Untitled
 
42 Wisløff, Finn; Brinch, Lorentz; Hammerstrøm, Jens.
Nasjonalt handlingsprogram for kronisk myelogen leukemi. Tidsskrift for Den norske legeforening 2003 (2) s. 157-159
NTNU UiO Untitled
 
43 Wisløff, Finn Georg B.
A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony-stimulating factor: significant effects on quality of life. British Journal of Haematology 2003 ;Volum 120. s. 1037-1046
UiO Untitled
 
44 Wisløff, Finn Georg B.
Impact of age on survival after intensive therapy in newly diagnosed multiple myeloma. Multiple Myeloma: 9th International Workshop; 2003-05-23 - 2003-05-27
UiO Untitled
 
45 Wisløff, Finn Georg B.
In multiple myeloma, the extent of skeletal disease and response to therapy are more important predictors for quality of life than haemoglobin levels. Multiple Myeloma. 9th International Workshop; 2003-05-23 - 2003-05-27
UiO Untitled
 
46 Wisløff, Finn Georg B.
Laboratory diagnosis of the antiphospholipid syndrome. Thrombosis Research 2003 ;Volum 108. s. 263-271
UiO Untitled
 
47 Wisløff, Finn Georg B.
Nordic Myeloma Study Group Guidelines on the diagnosis and management of multiple myeloma. Multiple Myeloma. 9th international workshop; 2003-05-23 - 2003-05-27
UiO Untitled
 
48 Wisløff, Finn Georg B.
The extent of skeletal disease and response to therapy are more important predictors for quality of life than haemoglobin levels in multiple myeloma. 8th annual congress of the European Haematology Association; 2003-06-12 - 2003-06-15
UiO Untitled
 
49 Wisløff, Finn Georg B; Brinch, Lorentz; Hammerstrøm, Jens.
Nasjonalt handlingsprogram for kronisk myelogen leukemi. Tidsskrift for Den norske legeforening 2003 ;Volum 123. s. 157-159
UiO Untitled
 
50 Hellström-Lindberg, E.; Gulbrandsen, Nina; Lindberg, G.; Ahlgren, T; Dahl, I.M.S.; Dybedal, I.; Grimfors, G.; Hjorth, Martin; Kanter-Lewenshon, L.; Linder, O.; Lithman, M.; Löfvenberg, E.; Öberg, G.; Tangen, Jon-Magnus; Wisløff, Finn Georg B.
A valdiated dicision model for treating the anaemia of myelodyscplastic syndromes with erythropoietin + granulocyte colony-stimulating factor: significant effects on quality of life. British Journal of Haematology 2003 ;Volum 120. s. 1-10
UiO Untitled
 
    Vis neste liste